Development of a practical, asymmetric synthesis of the hepatitis C virus protease inhibitor MK-5172

Jeffrey Kuethe1, Yong-Li Zhong, Nobuyoshi Yasuda

  • 1Process Chemistry, Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065-0200, USA. Jeffrey_kuethe@merck.com

Organic Letters
|August 8, 2013
PubMed

Related Concept Videos